thesis-toulmin
/
wikidata
/
Login
Register
TriplyDB
Wikidata
Browser
Triples
Insights
Schema
BETA
Class frequency
Class hierarchy
SPARQL
GraphQL
BETA
Graphs
2
Q26769917-A9871BE2-9B00-4B11-9F23-E2C8C3B310D1
Q26769917-A9871BE2-9B00-4B11-9F23-E2C8C3B310D1
BestRank
Statement
http://www.wikidata.org/entity/statement/Q26769917-A9871BE2-9B00-4B11-9F23-E2C8C3B310D1
Potential therapeutic implications of IL-6/IL-6R/gp130-targeting agents in breast cancer
P2860
Q26769917-A9871BE2-9B00-4B11-9F23-E2C8C3B310D1
BestRank
Statement
http://www.wikidata.org/entity/statement/Q26769917-A9871BE2-9B00-4B11-9F23-E2C8C3B310D1
rank
NormalRank
type
BestRank
Statement
wasDerivedFrom
af8462f4d391f732239b7192be8d306402571bd2
P2860
A phase I, open-label study of siltuximab, an anti-IL-6 monoclonal antibody, in patients with B-cell non-Hodgkin lymphoma, multiple myeloma, or Castleman disease.